UCB rolls out key epilepsy program

A major global biopharmaceutical company is rolling out a series of "in-school training activities" in China to promote public awareness in epilepsy, a neurological or brain disorder.

UCB, which is based in Brussels in Belgium, linked up with the China Association Against Epilepsy, or CAAE, to launch its nationwide "Go-to School" campaign in Shanghai last month.

This was all part of the group's aim to support national efforts in helping children and their parents understand the effects of the illness.